Gene · 10038
Papers2,674
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,674
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Knockout of Poly(ADP-Ribose) Polymerase 1 in a Human Cell Line: An Influence on Base Excision Repair Reactions in Cellular Extracts. | Cells | 2024 | 38391916 | PubTator, text mining | PubMed |
| Statement of Retraction: Long non-coding RNA CCL2 promoted gastric cancer function via miR-128/ PARP2 signal pathway. | Bioengineered | 2024 | 38376872 | PubTator, text mining | PubMed |
| High-throughput screening assay for PARP-HPF1 interaction inhibitors to affect DNA damage repair. | Sci Rep | 2024 | 38365924 | PubTator, text mining | PubMed |
| Asymmetric nucleosome PARylation at DNA breaks mediates directional nucleosome sliding by ALC1. | Nat Commun | 2024 | 38307862 | PubTator, text mining | PubMed |
| PARP-2 mediates cardiomyocyte aging and damage induced by doxorubicin through SIRT1 Inhibition. | Apoptosis | 2024 | 38281279 | PubTator, text mining | PubMed |
| Seize the engine: Emerging cell cycle targets in breast cancer. | Clin Transl Med | 2024 | 38264947 | PubTator, text mining | PubMed |
| Hormone, Targeted, and Combinational Therapies for Breast Cancers: From Humans to Dogs. | Int J Mol Sci | 2024 | 38255807 | PubTator, text mining | PubMed |
| Translation into Clinical Practice of the G1-G7 Molecular Subgroup Classification of Glioblastoma: Comprehensive Demographic and Molecular Pathway Profiling. | Cancers (Basel) | 2024 | 38254850 | PubTator, text mining | PubMed |
| Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. | Sci Adv | 2024 | 38241363 | PubTator, text mining | PubMed |
| Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions. | J Cancer | 2024 | 38213724 | PubTator, text mining | PubMed |
| Development of PARP inhibitors in advanced prostate cancer. | Ther Adv Med Oncol | 2024 | 38205078 | PubTator, text mining | PubMed |
| Aspirin and Cancer Survival: An Analysis of Molecular Mechanisms. | Cancers (Basel) | 2024 | 38201650 | PubTator, text mining | PubMed |
| Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer. | Cell Death Dis | 2024 | 38182579 | PubTator, text mining | PubMed |
| Covalent PARylation of DNA base excision repair proteins regulates DNA demethylation. | Nat Commun | 2024 | 38167803 | PubTator, text mining | PubMed |
| Phthalimide-tethered isatins as novel poly(ADP-ribose) polymerase inhibitors: Design, synthesis, biological evaluations, and molecular modeling investigations. | Arch Pharm (Weinheim) | 2024 | 38100160 | PubTator, text mining | PubMed |
| Comparative analysis of SARS-CoV-2 variants Alpha (B.1.1.7), Gamma (P.1), Zeta (P.2) and Delta (B.1.617.2) in Vero-E6 cells: ultrastructural characterization of cytopathology and replication kinetics. | Braz J Infect Dis | 2024 | 38081327 | PubTator, text mining | PubMed |
| Regulatory apoptotic fragment of PARP1 complements catalytic fragment for PAR and DNA-dependent activity but inhibits DNA-induced catalytic stimulation of PARP2. | DNA Repair (Amst) | 2024 | 38029688 | PubTator, text mining | PubMed |
| DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids. | Nucleic Acids Res | 2024 | 38000390 | PubTator, text mining | PubMed |
| Comprehensive Genomic Analysis of Cemento-Ossifying Fibroma. | Mod Pathol | 2024 | 37995913 | PubTator, text mining | PubMed |
| PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics. | Semin Oncol | 2024 | 37880048 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10038/papers?page=9